Regen BioPharma RGBP
OTC RGBP
$0.00 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Regen BioPharma Inc (RGBP) Income towards Parent Company (2013 - 2026)

Updated

Regen BioPharma (RGBP) reported Income towards Parent Company of -$637,785 for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$167,292 a year earlier.

Analysis

Regen BioPharma Inc (RGBP) Income towards Parent Company (2013 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Regen BioPharma's Income towards Parent Company came in at -$2.35 million; for FY2025 (ended Sep 30, 2025), it was -$1.27 million.

  • By fiscal year, Income towards Parent Company came in at -$668,255 in FY2024, $1.16 million in FY2023 (-52.7%), $2.44 million in FY2022 and -$6.77 million in FY2021.
  • Five-year quarterly Income towards Parent Company spans a low of -$67.08 million in fiscal Q2 2022 and a high of $66.96 million in fiscal Q3 2022.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -637,785.00
Dec 31, 2025 -967,853.00
Sep 30, 2025 -572,469.00
Jun 30, 2025 -167,292.00
Mar 31, 2025 -19,354.00
Dec 31, 2024 -515,384.00
Sep 30, 2024 -270,748.00
Jun 30, 2024 -130,120.00
Mar 31, 2024 -122,454.00
Dec 31, 2023 -349,760.00
Sep 30, 2023 -325,027.00
Jun 30, 2023 -99,218.00
Mar 31, 2023 -54,978.00
Dec 31, 2022 1.64 Mn
Sep 30, 2022 -78,026.00
Jun 30, 2022 66.96 Mn
Mar 31, 2022 -67.08 Mn
Dec 31, 2021 2.64 Mn
Sep 30, 2021 -1.38 Mn
Jun 30, 2021 -7.49 Mn
API Access

Regen BioPharma Inc Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=RGBP&period=max&api_key=YOUR_API_KEY